259 related articles for article (PubMed ID: 31577957)
21. Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.
Martín-Rufián M; Nascimento-Gomes R; Higuero A; Crisma AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Cheng T; Lobo C; Segura JA; Alonso FJ; Szeliga M; Albrecht J; Curi R; Márquez J; Colquhoun A; Deberardinis RJ; Matés JM
J Mol Med (Berl); 2014 Mar; 92(3):277-90. PubMed ID: 24276018
[TBL] [Abstract][Full Text] [Related]
22. Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells.
Huang T; Liu R; Fu X; Yao D; Yang M; Liu Q; Lu WW; Wu C; Guan M
Stem Cells; 2017 Feb; 35(2):411-424. PubMed ID: 27501743
[TBL] [Abstract][Full Text] [Related]
23. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer.
Kim S; Kim DH; Jung WH; Koo JS
Endocr Relat Cancer; 2013 Jun; 20(3):339-48. PubMed ID: 23507704
[TBL] [Abstract][Full Text] [Related]
24. Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer.
Saha SK; Islam SMR; Abdullah-Al-Wadud M; Islam S; Ali F; Park KS
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871151
[TBL] [Abstract][Full Text] [Related]
25. Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism.
Martín-Rufián M; Tosina M; Campos-Sandoval JA; Manzanares E; Lobo C; Segura JA; Alonso FJ; Matés JM; Márquez J
PLoS One; 2012; 7(6):e38380. PubMed ID: 22679499
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.
Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J
Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493
[TBL] [Abstract][Full Text] [Related]
27. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
Boysen G; Jamshidi-Parsian A; Davis MA; Siegel ER; Simecka CM; Kore RA; Dings RPM; Griffin RJ
Int J Radiat Biol; 2019 Apr; 95(4):436-442. PubMed ID: 30557074
[TBL] [Abstract][Full Text] [Related]
28. The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer.
Masisi BK; El Ansari R; Alfarsi L; Craze ML; Jewa N; Oldfield A; Cheung H; Toss M; Rakha EA; Green AR
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439127
[TBL] [Abstract][Full Text] [Related]
29. The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers.
Basheer HA; Elsalem L; Salem A; Tailor A; Hunter K; Afarinkia K
Curr Cancer Drug Targets; 2022; 22(2):169-179. PubMed ID: 34951574
[TBL] [Abstract][Full Text] [Related]
30. Regulation of hepatic glutamine metabolism by miR-122.
Sengupta D; Cassel T; Teng KY; Aljuhani M; Chowdhary VK; Hu P; Zhang X; Fan TW; Ghoshal K
Mol Metab; 2020 Apr; 34():174-186. PubMed ID: 32180557
[TBL] [Abstract][Full Text] [Related]
31. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.
Szeliga M; Albrecht J
Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.
Li HJ; Li X; Pang H; Pan JJ; Xie XJ; Chen W
Jpn J Clin Oncol; 2015 Nov; 45(11):1055-63. PubMed ID: 26373319
[TBL] [Abstract][Full Text] [Related]
33. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation.
Velletri T; Romeo F; Tucci P; Peschiaroli A; Annicchiarico-Petruzzelli M; Niklison-Chirou MV; Amelio I; Knight RA; Mak TW; Melino G; Agostini M
Cell Cycle; 2013 Nov; 12(22):3564-73. PubMed ID: 24121663
[TBL] [Abstract][Full Text] [Related]
34. Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells.
Kuo TC; Chen CK; Hua KT; Yu P; Lee WJ; Chen MW; Jeng YM; Chien MH; Kuo KT; Hsiao M; Kuo ML
Cancer Lett; 2016 Dec; 383(2):282-294. PubMed ID: 27725225
[TBL] [Abstract][Full Text] [Related]
35. GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.
Suzuki S; Venkatesh D; Kanda H; Nakayama A; Hosokawa H; Lee E; Miki T; Stockwell BR; Yokote K; Tanaka T; Prives C
Cancer Res; 2022 Sep; 82(18):3209-3222. PubMed ID: 35895807
[TBL] [Abstract][Full Text] [Related]
36. p63 regulates glutaminase 2 expression.
Giacobbe A; Bongiorno-Borbone L; Bernassola F; Terrinoni A; Markert EK; Levine AJ; Feng Z; Agostini M; Zolla L; Agrò AF; Notterman DA; Melino G; Peschiaroli A
Cell Cycle; 2013 May; 12(9):1395-405. PubMed ID: 23574722
[TBL] [Abstract][Full Text] [Related]
37. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
[TBL] [Abstract][Full Text] [Related]
38. [
Zhou R; Pantel AR; Li S; Lieberman BP; Ploessl K; Choi H; Blankemeyer E; Lee H; Kung HF; Mach RH; Mankoff DA
Cancer Res; 2017 Mar; 77(6):1476-1484. PubMed ID: 28202527
[TBL] [Abstract][Full Text] [Related]
39. Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer.
Matés JM; Segura JA; Martín-Rufián M; Campos-Sandoval JA; Alonso FJ; Márquez J
Curr Mol Med; 2013 May; 13(4):514-34. PubMed ID: 22934847
[TBL] [Abstract][Full Text] [Related]
40. Metabolic fingerprinting reveals extensive consequences of GLS hyperactivity.
Rumping L; Pras-Raves ML; Gerrits J; Tang YF; Willemsen MA; Houwen RHJ; van Haaften G; van Hasselt PM; Verhoeven-Duif NM; Jans JJM
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129484. PubMed ID: 31734463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]